한글목차

일반 의약품 시장은 2024-2029년 596억 달러 증가하고, 예측 기간 중 연평균 복합 성장률(CAGR)은 6%를 보일 것으로 예측됩니다.

세계의 일반의약품 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.

현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 세계 일반의약품 시장의 신제품 출시, 질병 유병률 증가와 일반의약품 사용 증가, 일반의약품에 대한 유리한 규제 프레임워크 등이 시장을 주도하고 있습니다.

이 조사는 업계 주요 참가자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역별 분석에 따른 부문, 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.

이 보고서는 향후 몇 년 동안 일반의약품 시장의 성장을 가속하는 주요 이유 중 하나로 노인 인구 증가를 꼽았습니다. 또한, 헬스케어 지출 증가와 전자상거래 플랫폼을 통한 일반의약품의 보급도 시장의 큰 수요로 이어질 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 Technavio 분석

• 가격, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
• 인풋의 중요성과 차별화 요인
• 혼란 요인
• 성장 촉진요인과 과제의 영향

제3장 시장 구도

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제4장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2024년)
• 시장 전망 2024년-2029년

제5장 시장 규모 실적

• 세계의 일반 의약품 시장(2019-2023년)
• 유통 채널별 부문 분석(2019-2023년)
• 투여 경로별 부문 분석(2019-2023년)
• 제제별 부문 분석(2019-2023년)
• 지역별 부문 분석(2019-2023년)
• 국가별 부문 분석(2019-2023년)

제6장 정성 분석

• AI의 영향 - 일반 의약품 시장

제7장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제8장 시장 세분화 : 유통 채널별

• 시장 부문
• 비교 : 유통 채널별
• 오프라인 : 시장 규모와 예측(2024-2029년)
• 온라인 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 유통 채널별

제9장 시장 세분화 : 투여 경로별

• 시장 부문
• 비교 : 투여 경로별
• 경구 : 시장 규모와 예측(2024-2029년)
• 국소 : 시장 규모와 예측(2024-2029년)
• 비경구 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 투여 경로별

제10장 시장 세분화 : 제제별

• 시장 부문
• 비교 : 제제별
• 정제 및 캡슐 : 시장 규모와 예측(2024-2029년)
• 액체 및 시럽 : 시장 규모와 예측(2024-2029년)
• 크림 및 연고 : 시장 규모와 예측(2024-2029년)
• 분말 : 시장 규모와 예측(2024-2029년)
• 스프레이 및 점안약 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 제제별

제11장 고객 상황

• 고객 상황 개요

제12장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2024-2029년)
• 유럽 : 시장 규모와 예측(2024-2029년)
• 아시아 : 시장 규모와 예측(2024-2029년)
• 세계 기타 지역 : 시장 규모와 예측(2024-2029년)
• 중국 : 시장 규모와 예측(2024-2029년)
• 독일 : 시장 규모와 예측(2024-2029년)
• 일본 : 시장 규모와 예측(2024-2029년)
• 미국 : 시장 규모와 예측(2024-2029년)
• 캐나다 : 시장 규모와 예측(2024-2029년)
• 영국 : 시장 규모와 예측(2024-2029년)
• 프랑스 : 시장 규모와 예측(2024-2029년)
• 인도 : 시장 규모와 예측(2024-2029년)
• 멕시코 : 시장 규모와 예측(2024-2029년)
• 이탈리아 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 지역 상황별

제13장 시장 성장 촉진요인, 과제, 기회 및 성장 억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회와 성장 억제요인

제14장 경쟁 구도

• 개요
• 경쟁 구도
• 파괴적 혁신 상황
• 업계 리스크

제15장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• Abbott Laboratories
• Achelios Therapeutics Inc.
• AstraZeneca Plc
• Bayer AG
• BioGaia AB
• Boehringer Ingelheim International GmbH
• Bukwang Pharmaceutical Co. Ltd.
• Chr Hansen AS
• CVS Health Corp.
• GlaxoSmithKline Plc
• Johnson and Johnson Services Inc.
• Novartis AG
• Pfizer Inc.
• Reckitt Benckiser Group Plc
• Sanofi SA

제16장 부록

영문목차

The over-the-counter (OTC) drug market is forecasted to grow by USD 59.6 bn during 2024-2029, accelerating at a CAGR of 6% during the forecast period. The report on the over-the-counter (OTC) drug market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by new product launches in global over-the-counter (OTC) drug market, rising prevalence of diseases and otc drug use, and favorable regulatory framework for otc drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's over-the-counter (OTC) drug market is segmented as below:

By Distribution Channel

• Offline
• Online

By Route Of Administration

• Oral
• Topical
• Parenteral

By Formulation

• Tablets and capsules
• Liquids and syrups
• Creams and ointments
• Powders
• Sprays and drops

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing number of geriatric population as one of the prime reasons driving the over-the-counter (OTC) drug market growth during the next few years. Also, increasing healthcare expenditure and growing adoption of e-commerce platform for otc drugs will lead to sizable demand in the market.

The report on the over-the-counter (OTC) drug market covers the following areas:

• Over-The-Counter (OTC) Drug Market sizing
• Over-The-Counter (OTC) Drug Market forecast
• Over-The-Counter (OTC) Drug Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading over-the-counter (OTC) drug market vendors that include Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Bukwang Pharmaceutical Co. Ltd., Chr Hansen AS, Cipla Inc., CVS Health Corp., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Lupin Ltd., Mankind Pharma Ltd., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi SA, and Zydus Lifesciences Ltd.. Also, the over-the-counter (OTC) drug market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Market Segmentation by Route of Administration
  • Executive Summary - Chart on Market Segmentation by Formulation
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Global - Market size and forecast 2024-2029 ($ billion)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Over-The-Counter (OTC) Drug Market 2019 - 2023
  • Historic Market Size - Data Table on Global Over-The-Counter (OTC) Drug Market 2019 - 2023 ($ billion)
• 5.2 Distribution Channel segment analysis 2019 - 2023
  • Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion)
• 5.3 Route of Administration segment analysis 2019 - 2023
  • Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion)
• 5.4 Formulation segment analysis 2019 - 2023
  • Historic Market Size - Formulation Segment 2019 - 2023 ($ billion)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

• 6.1 The AI impact in the global over-the-counter (OTC) drug market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Distribution Channel

• 8.1 Market segments
  • Chart on Distribution Channel - Market share 2024-2029 (%)
  • Data Table on Distribution Channel - Market share 2024-2029 (%)
• 8.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 8.3 Offline - Market size and forecast 2024-2029
  • Chart on Offline - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Offline - Market size and forecast 2024-2029 ($ billion)
  • Chart on Offline - Year-over-year growth 2024-2029 (%)
  • Data Table on Offline - Year-over-year growth 2024-2029 (%)
• 8.4 Online - Market size and forecast 2024-2029
  • Chart on Online - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Online - Market size and forecast 2024-2029 ($ billion)
  • Chart on Online - Year-over-year growth 2024-2029 (%)
  • Data Table on Online - Year-over-year growth 2024-2029 (%)
• 8.5 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ billion)
  • Data Table on Market opportunity by Distribution Channel ($ billion)

9 Market Segmentation by Route of Administration

• 9.1 Market segments
  • Chart on Route of Administration - Market share 2024-2029 (%)
  • Data Table on Route of Administration - Market share 2024-2029 (%)
• 9.2 Comparison by Route of Administration
  • Chart on Comparison by Route of Administration
  • Data Table on Comparison by Route of Administration
• 9.3 Oral - Market size and forecast 2024-2029
  • Chart on Oral - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Oral - Market size and forecast 2024-2029 ($ billion)
  • Chart on Oral - Year-over-year growth 2024-2029 (%)
  • Data Table on Oral - Year-over-year growth 2024-2029 (%)
• 9.4 Topical - Market size and forecast 2024-2029
  • Chart on Topical - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Topical - Market size and forecast 2024-2029 ($ billion)
  • Chart on Topical - Year-over-year growth 2024-2029 (%)
  • Data Table on Topical - Year-over-year growth 2024-2029 (%)
• 9.5 Parenteral - Market size and forecast 2024-2029
  • Chart on Parenteral - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Parenteral - Market size and forecast 2024-2029 ($ billion)
  • Chart on Parenteral - Year-over-year growth 2024-2029 (%)
  • Data Table on Parenteral - Year-over-year growth 2024-2029 (%)
• 9.6 Market opportunity by Route of Administration
  • Market opportunity by Route of Administration ($ billion)
  • Data Table on Market opportunity by Route of Administration ($ billion)

10 Market Segmentation by Formulation

• 10.1 Market segments
  • Chart on Formulation - Market share 2024-2029 (%)
  • Data Table on Formulation - Market share 2024-2029 (%)
• 10.2 Comparison by Formulation
  • Chart on Comparison by Formulation
  • Data Table on Comparison by Formulation
• 10.3 Tablets and capsules - Market size and forecast 2024-2029
  • Chart on Tablets and capsules - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Tablets and capsules - Market size and forecast 2024-2029 ($ billion)
  • Chart on Tablets and capsules - Year-over-year growth 2024-2029 (%)
  • Data Table on Tablets and capsules - Year-over-year growth 2024-2029 (%)
• 10.4 Liquids and syrups - Market size and forecast 2024-2029
  • Chart on Liquids and syrups - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Liquids and syrups - Market size and forecast 2024-2029 ($ billion)
  • Chart on Liquids and syrups - Year-over-year growth 2024-2029 (%)
  • Data Table on Liquids and syrups - Year-over-year growth 2024-2029 (%)
• 10.5 Creams and ointments - Market size and forecast 2024-2029
  • Chart on Creams and ointments - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Creams and ointments - Market size and forecast 2024-2029 ($ billion)
  • Chart on Creams and ointments - Year-over-year growth 2024-2029 (%)
  • Data Table on Creams and ointments - Year-over-year growth 2024-2029 (%)
• 10.6 Powders - Market size and forecast 2024-2029
  • Chart on Powders - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Powders - Market size and forecast 2024-2029 ($ billion)
  • Chart on Powders - Year-over-year growth 2024-2029 (%)
  • Data Table on Powders - Year-over-year growth 2024-2029 (%)
• 10.7 Sprays and drops - Market size and forecast 2024-2029
  • Chart on Sprays and drops - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Sprays and drops - Market size and forecast 2024-2029 ($ billion)
  • Chart on Sprays and drops - Year-over-year growth 2024-2029 (%)
  • Data Table on Sprays and drops - Year-over-year growth 2024-2029 (%)
• 10.8 Market opportunity by Formulation
  • Market opportunity by Formulation ($ billion)
  • Data Table on Market opportunity by Formulation ($ billion)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ billion)
  • Data Table on North America - Market size and forecast 2024-2029 ($ billion)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 12.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 12.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 12.7 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ billion)
  • Data Table on China - Market size and forecast 2024-2029 ($ billion)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 12.8 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 12.9 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 12.10 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ billion)
  • Data Table on US - Market size and forecast 2024-2029 ($ billion)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 12.11 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 12.12 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ billion)
  • Data Table on UK - Market size and forecast 2024-2029 ($ billion)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 12.13 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ billion)
  • Data Table on France - Market size and forecast 2024-2029 ($ billion)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 12.14 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ billion)
  • Data Table on India - Market size and forecast 2024-2029 ($ billion)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 12.15 Mexico - Market size and forecast 2024-2029
  • Chart on Mexico - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Mexico - Market size and forecast 2024-2029 ($ billion)
  • Chart on Mexico - Year-over-year growth 2024-2029 (%)
  • Data Table on Mexico - Year-over-year growth 2024-2029 (%)
• 12.16 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
• 12.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ billion)
  • Data Tables on Market opportunity By Geographical Landscape ($ billion)

13 Drivers, Challenges, and Opportunity/Restraints

• 13.1 Market drivers
• 13.2 Market challenges
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities/restraints

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Achelios Therapeutics Inc.
  • Achelios Therapeutics Inc. - Overview
  • Achelios Therapeutics Inc. - Product / Service
  • Achelios Therapeutics Inc. - Key offerings
  • SWOT
• 15.6 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
  • SWOT
• 15.7 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
  • SWOT
• 15.8 BioGaia AB
  • BioGaia AB - Overview
  • BioGaia AB - Business segments
  • BioGaia AB - Key offerings
  • BioGaia AB - Segment focus
  • SWOT
• 15.9 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings
  • SWOT
• 15.10 Bukwang Pharmaceutical Co. Ltd.
  • Bukwang Pharmaceutical Co. Ltd. - Overview
  • Bukwang Pharmaceutical Co. Ltd. - Product / Service
  • Bukwang Pharmaceutical Co. Ltd. - Key offerings
  • SWOT
• 15.11 Chr Hansen AS
  • Chr Hansen AS - Overview
  • Chr Hansen AS - Business segments
  • Chr Hansen AS - Key news
  • Chr Hansen AS - Key offerings
  • Chr Hansen AS - Segment focus
  • SWOT
• 15.12 CVS Health Corp.
  • CVS Health Corp. - Overview
  • CVS Health Corp. - Business segments
  • CVS Health Corp. - Key offerings
  • CVS Health Corp. - Segment focus
  • SWOT
• 15.13 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
  • SWOT
• 15.14 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
  • SWOT
• 15.15 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
  • SWOT
• 15.16 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 15.17 Reckitt Benckiser Group Plc
  • Reckitt Benckiser Group Plc - Overview
  • Reckitt Benckiser Group Plc - Business segments
  • Reckitt Benckiser Group Plc - Key news
  • Reckitt Benckiser Group Plc - Key offerings
  • Reckitt Benckiser Group Plc - Segment focus
  • SWOT
• 15.18 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations